FDA approves Incyte's eczema cream with boxed warnings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 114.13 -1.17 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.30 | 52 Week High | $118.49 | |||
| Open | $115.14 | 52 Week Low | $55.00 | |||
| Day High | $115.67 | P/E | N/A | |||
| Day Low | $112.83 | EPS | $-0.56 | |||
| Volume | 1,948,758 | |||||
